Diminished ovarian reserve in young women with sickle cell anemia
- PMID: 34864892
- PMCID: PMC8854680
- DOI: 10.1182/blood.2021012756
Diminished ovarian reserve in young women with sickle cell anemia
Abstract
Women with sickle cell anemia (SCA) have higher rates of diminished ovarian reserve (DOR) than age-matched controls. Pecker et al report a small study of patients with SCA that compares ovarian reserve in patients after stem cell transplant, on therapy with hydroxyurea (HU), and on supportive care. As expected, patients who received transplants have severe DOR. About one-third of patients on HU have DOR, while DOR was absent in patients on supportive care. Whether this reflects an impact of HU or is a biomarker of severe disease remains to be established in a larger study.
Comment in
-
Reproductive equity: preserve the reserve.Blood. 2022 Feb 17;139(7):963-965. doi: 10.1182/blood.2021015021. Blood. 2022. PMID: 35175326 No abstract available.
-
Detrimental effects of sickle cell disease and hydroxycarbamide on ovarian reserve but uncertain impact on fertility.Blood Adv. 2023 Sep 12;7(17):4794-4798. doi: 10.1182/bloodadvances.2022008859. Blood Adv. 2023. PMID: 36989137 Free PMC article. No abstract available.
Similar articles
-
Egg Quality and Pregnancy Outcome in Young Infertile Women with Diminished Ovarian Reserve.Med Sci Monit. 2018 Oct 12;24:7279-7284. doi: 10.12659/MSM.910410. Med Sci Monit. 2018. PMID: 30310048 Free PMC article.
-
Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide.Br J Haematol. 2020 Dec;191(5):880-887. doi: 10.1111/bjh.16976. Epub 2020 Jul 26. Br J Haematol. 2020. PMID: 32712966 Free PMC article. Clinical Trial.
-
A recurrent mutation in TBPL2 causes diminished ovarian reserve and female infertility.J Genet Genomics. 2020 Dec 20;47(12):785-788. doi: 10.1016/j.jgg.2020.09.004. Epub 2020 Nov 18. J Genet Genomics. 2020. PMID: 33541821 No abstract available.
-
Diminished ovarian reserve versus ovarian aging: overlaps and differences.Curr Opin Obstet Gynecol. 2019 Jun;31(3):139-147. doi: 10.1097/GCO.0000000000000536. Curr Opin Obstet Gynecol. 2019. PMID: 30870184 Review.
-
Hyperactivation of dormant primordial follicles in ovarian endometrioma patients.Reproduction. 2020 Dec;160(6):R145-R153. doi: 10.1530/REP-20-0265. Reproduction. 2020. PMID: 33112785 Review.
Cited by
-
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women.Expert Rev Hematol. 2024 Aug;17(8):493-504. doi: 10.1080/17474086.2024.2372320. Epub 2024 Jun 26. Expert Rev Hematol. 2024. PMID: 38913857 Free PMC article. Review.
-
Ovarian Tissue Cryopreservation for Fertility Preservation in Patients with Hemoglobin Disorders: A Comprehensive Review.J Clin Med. 2024 Jun 21;13(13):3631. doi: 10.3390/jcm13133631. J Clin Med. 2024. PMID: 38999197 Free PMC article. Review.
-
Detrimental effects of sickle cell disease and hydroxycarbamide on ovarian reserve but uncertain impact on fertility.Blood Adv. 2023 Sep 12;7(17):4794-4798. doi: 10.1182/bloodadvances.2022008859. Blood Adv. 2023. PMID: 36989137 Free PMC article. No abstract available.
-
Expecting more: the case for incorporating fertility services into comprehensive sickle cell disease care.Lancet Haematol. 2023 Mar;10(3):e225-e234. doi: 10.1016/S2352-3026(22)00353-2. Epub 2023 Jan 25. Lancet Haematol. 2023. PMID: 36708736 Free PMC article. Review.
-
Pregnancy outcomes in women with sickle cell disease in California.Am J Hematol. 2023 Mar;98(3):440-448. doi: 10.1002/ajh.26818. Epub 2023 Jan 4. Am J Hematol. 2023. PMID: 36594168 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
